Richard C Friesner

Title: Richard C. Friesner: Innovator in Collaborative Drug Discovery

Introduction

Richard C. Friesner is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of drug discovery through his innovative ideas and systems. His work focuses on enhancing collaboration in drug discovery processes, which is crucial for advancing medical research and development.

Latest Patents

Friesner holds a patent for a "Collaborative Drug Discovery System." This patent outlines methods and systems for creating electronic workplaces that facilitate collaborative drug discovery. These workplaces are accessible simultaneously by multiple user computing devices, allowing for efficient communication and data sharing among researchers. The server-side application communicates with electronic databases to define the parameters of each workplace, ensuring that all users have access to the most up-to-date information.

Career Highlights

Friesner is associated with Schrödinger, Inc., a company known for its cutting-edge software solutions in drug discovery and materials science. His work at Schrödinger has positioned him as a key player in the field, contributing to advancements that streamline the drug discovery process.

Collaborations

Throughout his career, Friesner has collaborated with notable colleagues, including Scott Becker and Brian Schoolman. These collaborations have further enriched his work and have led to innovative solutions in the realm of drug discovery.

Conclusion

Richard C. Friesner's contributions to collaborative drug discovery exemplify the importance of innovation in the medical field. His patent and work at Schrödinger, Inc. highlight his commitment to enhancing research collaboration, ultimately benefiting the advancement of healthcare solutions.